Members of the World Professional Association for Transgender Health have some concerns
Laura Edwards-Leeper, a psychologist who helped found America’s first clinic for transgender children in Boston in 2007, has stated (even to this newspaper) that very few adolescents undergo crucial mental health screenings before starting hormone-blocking and gender transition treatments for gender dysphoria (The Economist, October 16, 2021).
Very few adolescents undergo crucial mental health screenings before starting hormone-blocking and gender transition treatments for gender dysphoria
Referring to comments from Dr. Bowers, a vaginoplasty surgeon who will become president of WPATH in 2022, especially on the effects of blockers on sexual function, she claims that they have “shaken” many in this field. Bowers has stated that she was not a fan “of putting children on blockers at the beginning of puberty. On the contrary, she claimed to worry,” about their reproductive rights later. I am concerned about their sexual health later on and their ability to find intimacy. “
Some doctors are considering how they might control or delay hormone transition and blocking treatments, ignoring the role that mental health professionals should play in all of this. However, that they are discussing risks is progress.
Concerns about the use of puberty blockers, which are prescribed to some boys to prevent the development of secondary sexual characteristics (such as breasts and facial hair), have risen in much of the rich world.
Puberty blockers questioned by doctors working in transgender clinics
Some countries have reduced its use, but in the United States, this trend does not occur. Doctors working in clinics for transgender people routinely claim that prescribing these drugs is conservative, because their effects are largely reversible and compassionate because they save children with gender dysphoria (the feeling of being in the wrong body) from enormous anguish. But this is being hotly debated around the world and now in the United States as well.
Last week, Abigail Shrier, a writer, published interviews in “Common Sense With Bari Weiss,” a newsletter, with two transgender health professionals who suggested that some doctors were irresponsible in the way they treated children.
The trans-women on the board of the World Professional Association for Transgender Health (WPATH), which endorses the use of blockers in the early stages of puberty in some cases.
The combination of treatments aimed at blocking hormonal changes that occur in adolescence, followed by other cross-hormonal treatments aimed at promoting the sexual characteristics of the opposite sex, can have irreversible consequences, including sterility and the inability to reach orgasm. We have published several articles about the negative effects of these experimental treatments some of them irreversible.
In 2018, Lisa Littman, a researcher, was persecuted and lost her consulting job after coining the term “rapid-onset gender dysphoria” to describe the influence that rapidly spreading and normalizing attitudes can have on adolescents, especially girls, who show a tendency to imitate transsexual tendencies as a solution to certain maturational problems.
Dr. Bowers stated in this regard that “there are probably people who are influenced. There’s a bit of “Yeah, that’s so cool. Yeah, I kind of want to do that too.” In some cases, she said, girls with eating disorders were diagnosed with gender dysphoria, “and then they see you for one visit, and then they recommend testosterone.”